Paliperidon Krka (Paliperidone)

Paliperidone, the active ingredient in Paliperidon Krka, is an antipsychotic presented as a tablet for oral use. It is used to manage symptoms of schizophrenia and schizoaffective disorder in adults.

GNH USA supplies Paliperidon Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Paliperidone is an atypical antipsychotic that modulates dopamine and serotonin pathways in psychotic disorders. - Schizophrenia: helps reduce hallucinations, delusions and thought disorder. - Schizoaffective disorder: improves mood symptoms and psychotic features. - Maintenance therapy: helps prevent relapse of psychotic episodes after stabilization.

Paliperidone may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Akathisia: feeling of inner restlessness. - Drowsiness or somnolence. - Weight gain. - Dry mouth. - Constipation. - Increased prolactin levels.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome: high fever, muscle rigidity, autonomic instability. - Tardive dyskinesia: involuntary, repetitive movements. - Seizures: especially in patients with a history of epilepsy. - Orthostatic hypotension: marked drop in blood pressure upon standing. - Hyperglycaemia: elevated blood glucose levels, may worsen diabetes.

When prescribing Paliperidone, clinicians should consider several safety aspects. - Cardiovascular assessment: evaluate baseline ECG and monitor for QT prolongation. - Metabolic monitoring: check weight, fasting glucose, and lipid profile regularly. - Prolactin monitoring: assess for galactorrhea, menstrual changes, or sexual dysfunction. - CNS effects: advise patients about drowsiness and avoid operating heavy machinery. - Pregnancy and lactation: use only if benefits outweigh risks; discuss with obstetric specialist. - Store at ambient temperature: keep below 25°C, in the original container, protected from moisture and light.

Paliperidone can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole) – may increase paliperidone levels. - Strong CYP3A4 inducers: (e.g., rifampicin) – may reduce the  ...